A medical breakthrough was reported Monday in the journal The Lancet wherein the results of a therapy using human embryonic stem cells in two legally blind patients was described.
Day: January 24, 2012
Montefiore vision experts encourage public to learn more about glaucoma
January is National Glaucoma Awareness Month. Vision experts at Montefiore Medical Center encourage the public to learn more about this disease, which is the leading cause of preventable blindness in the United States.
New gene therapy shows promise against X-linked retinitis pigmentosa
A new gene therapy method developed by University of Florida researchers has the potential to treat a common form of blindness that strikes both youngsters and adults.
Retinitis Pigmentosa In Dogs Cured By Gene Therapy
Members of a University of Pennsylvania research team have shown that they can prevent, or even reverse, a blinding retinal disease, X-linked Retinitis Pigmentosa, or XLRP, in dogs. The disease in humans and dogs is caused by defects in the RPGR gene a…
RPB awards $220,000 to SUNY Downstate for eye research
Capping SUNY Downstate Medical Center’s growth into a major center for eye research, Research to Prevent Blindness (RPB) has awarded SUNY Downstate a four-year challenge grant of $220,000 to spur the development of advanced research into the causes, tr…
Stem Cells in Ophthalmology Update 16: Results of First Embryonic Stem Cells in Treatment of Eye Disease Reported in Peer-Reviewed Journal
Two significant events were reported today by Advanced Cell Technology. First, the company said that a peer-reviewed publication of clinical results from its first patients treated at UCLA Jules Stein Eye Institute had been placed online by the UK’s …